Breast cancer and (25R)-26-hydroxycholesterol

Steroids

Volumn 104, Issue , 2015, Pages 61-64

  Javitt, Norman B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

27 Hydroxycholesterol; Breast cancer; Estrogen receptor positive; Lanosterol to cholesterol transformation; Sterol intermediates; Tamoxifen

Indexed keywords

26 HYDROXYCHOLESTEROL; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; LANOSTEROL; OXYGENASE; OXYSTEROL; OXYSTEROL 7 ALPHA HYDROXYLASE; TAMOXIFEN; UNCLASSIFIED DRUG; 27-HYDROXYCHOLESTEROL; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CHOLESTEROL DERIVATIVE; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL INFILTRATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DRUG EFFECT; HUMAN; MACROPHAGE; TISSUE LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CHEMISTRY; FEMALE; METABOLISM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MACROPHAGES; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 84948110783     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2015.08.012     Document Type: Review

References (37)

1. R.J. Fakheri, and N.B. Javitt 27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols Steroids 77 2012 575 577
2. Q. Wu, T. Ishikawa, R. Sirianni, H. Tang, J.G. McDonald, I.S. Yuhanna, and et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth Cell Rep. 5 2013 637 645
3. E.R. Nelson, S.E. Wardell, J.S. Jasper, S. Park, S. Suchindran, M.K. Howe, and et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology Science 342 2013 1094 1098
4. M. Umetani, H. Domoto, A.K. Gormley, I.S. Yuhanna, C.L. Cummins, N.B. Javitt, and et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen Nat. Med. 13 2007 1185 1192
5. P. Cruz, C. Torres, M.E. Ramirez, M.J. Epunan, L.E. Valladares, and W.D. Sierralta Proliferation of human mammary cancer cells exposed to 27-hydroxycholesterol Exp. Ther. Med. 1 2010 531 536
6. A.M. Tower, A. Trinward, K. Lee, L. Joseph, H.I. Jacobson, J.A. Bennett, and et al. AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats Oncol. Rep. 22 2009 49 56
7. J. De Caprio, J. Yun, and N.B. Javitt Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin J. Lipid Res. 33 1992 441 443
8. S. Andersson, D.L. Davis, H. Dahlback, H. Jornvall, and D.W. Russell Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme J. Biol. Chem. 264 1989 8222 8229
9. N.B. Javitt, E. Kok, S. Burstein, B. Cohen, and J. Kutscher 26-Hydroxycholesterol. Identification and quantitation in human serum J. Biol. Chem. 256 1981 12644 12646
10. K.E. Anderson, E. Kok, and N.B. Javitt Bile acid synthesis in man: metabolism of 7 -hydroxycholesterol- 14 C and 26-hydroxycholesterol- 3 H J. Clin. Investig. 51 1972 112 117
11. A. Babiker, O. Andersson, E. Lund, R.J. Xiu, S. Deeb, A. Reshef, and et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport J. Biol. Chem. 272 1997 26253 26261
12. C.M. Quinn, W. Jessup, J. Wong, L. Kritharides, and A.J. Brown Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands Biochem. J. 385 2005 823 830
13. M. Hansson, K. Wikvall, and A. Babiker Regulation of sterol 27-hydroxylase in human monocyte-derived macrophages: up-regulation by transforming growth factor beta1 Biochim. Biophys. Acta 1687 2005 44 51
14. V.M. Olkkonen Macrophage oxysterols and their binding proteins: roles in atherosclerosis Curr. Opin. Lipidol. 23 2012 462 470
15. A. Babiker, O. Andersson, D. Lindblom, J. van der Linden, B. Wiklund, D. Lutjohann, and et al. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin J. Lipid Res. 40 1999 1417 1425
16. J.G. McDonald, D.D. Smith, A.R. Stiles, and D.W. Russell A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma J. Lipid Res. 53 2012 1399 1409
17. I. Bjorkhem, L. Starck, U. Andersson, D. Lutjohann, S. von Bahr, I. Pikuleva, and et al. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol J. Lipid Res. 42 2001 366 371
18. I.A. Pikuleva, A. Babiker, M.R. Waterman, and I. Bjorkhem Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways J. Biol. Chem. 273 1998 18153 18160
19. A.B. Reiss, K.O. Martin, N.B. Javitt, D.W. Martin, E.A. Grossi, and A.C. Galloway Sterol 27-hydroxylase: high levels of activity in vascular endothelium J. Lipid Res. 35 1994 1026 1030
20. J.M. Gwak, M.H. Jang, D.I. Kim, A.N. Seo, and S.Y. Park Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer PLoS ONE 10 2015 e0125728
21. N. Zhou, Y. Zhang, X. Zhang, Z. Lei, R. Hu, H. Li, and et al. Exposure of tumor-associated macrophages to apoptotic mcf-7 cells promotes breast cancer growth and metastasis Int. J. Mol. Sci. 16 2015 11966 11982
22. C.G. Torres, M.E. Ramirez, P. Cruz, M.J. Epunan, L.E. Valladares, and W.D. Sierralta 27-hydroxycholesterol induces the transition of MCF7 cells into a mesenchymal phenotype Oncol. Rep. 26 2011 389 397
23. Z. Wu, K.O. Martin, N.B. Javitt, and J.Y. Chiang Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1 J. Lipid Res. 40 1999 2195 2203
24. W. Tang, G. Eggertsen, J.Y. Chiang, and M. Norlin Estrogen-mediated regulation of CYP7B1: a possible role for controlling DHEA levels in human tissues J. Steroid Biochem. Mol. Biol. 100 2006 42 51
25. C.A. Wassif, P.A. Krakowiak, B.S. Wright, J.S. Gewandter, A.L. Sterner, N. Javitt, and et al. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts Mol. Genet. Metab. 85 2005 96 107
26. C.A. Wassif, J. Yu, J. Cui, F.D. Porter, and N.B. Javitt 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway Steroids 68 2003 497 502
27. I. Pikuleva, and N.B. Javitt Novel sterols synthesized via the CYP27A1 metabolic pathway Arch. Biochem. Biophys. 420 2003 35 39
28. H. Gylling, E. Mantyla, and T.A. Miettinen Tamoxifen decreases serum cholesterol by inhibiting cholesterol synthesis Atherosclerosis 96 1992 245 247
29. P. de Medina, M.R. Paillasse, G. Segala, F. Khallouki, S. Brillouet, F. Dalenc, and et al. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands Chem. Phys. Lipids 164 2011 432 437
30. S.Y. Cho, J.H. Kim, and Y.K. Paik Cholesterol biosynthesis from lanosterol: differential inhibition of sterol delta 8-isomerase and other lanosterol-converting enzymes by tamoxifen Mol. Cells 8 1998 233 239
31. F. Heller Genetics/genomics and drug effects Acta Clin. Belg. 68 2013 77 80
32. Q. Feng, Z. Zhang, M.J. Shea, C.J. Creighton, C. Coarfa, S.G. Hilsenbeck, and et al. An epigenomic approach to therapy for tamoxifen-resistant breast cancer Cell Res. 24 2014 809 819
33. N. Nass, and T. Kalinski Tamoxifen resistance: from cell culture experiments towards novel biomarkers Pathol. Res. Pract. 211 2015 189 197
34. K.P. Battaile, B.C. Battaile, L.S. Merkens, C.L. Maslen, and R.D. Steiner Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome Mol. Genet. Metab. 72 2001 67 71
35. G.E. Herman Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes Hum. Mol. Genet. 12 Spec No 1 2003 R75 R88
36. K.P. Battaile, C.L. Maslen, C.A. Wassif, P. Krakowiak, F.D. Porter, and R.D. Steiner A simple PCR-based assay allows detection of a common mutation, IVS8-1G->C, in DHCR7 in Smith-Lemli-Opitz syndrome Genet. Test. 3 1999 361 363
37. P.E. Jira, R.A. Wevers, J. de Jong, E. Rubio-Gozalbo, F.S. Janssen-Zijlstra, A.F. van Heyst, and et al. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome J. Lipid Res. 41 2000 1339 1346